Effect of Long-Term Marine ɷ-3 Fatty Acids Supplementation on the Risk of Atrial Fibrillation in Randomized Controlled Trials of Cardiovascular Outcomes: A Systematic Review and Meta-Analysis

Gencer, Baris, Djousse, Luc, Al-Ramady, Omar T., Cook, Nancy R., Manson, JoAnn E., Albert, Christine M.·2021·Circulation
DOI 10.1161/circulationaha.121.055654

Cited by (150)

Items 101–150 of 150

  1. Effects of Omega-3 Fatty Acid Treatment on Risk for Atrial Fibrillation: An Updated Meta-Analysis of 35 Trials including 114 592 Individuals
    Abuknesha, Nada R., O’Keefe, James H, Qian, Frank, Tintle, Nathan L., Lin, Yidie, Sun, Yue, Qian, Han-Zhu, Aisen, Paul S., Albert, Christine M., Aronson, William J. et al. · 2026 · Circulation: Arrhythmia and Electrophysiology
  2. Dietary Supplement Use Is Associated with Select Serum Nutrient Biomarkers among Postmenopausal Women: Results from a Controlled Feeding Study
    Hannah T Baillie, Lesley Fels Tinker, Peng An, Theodore M. Brasky, Simin Liu, JoAnn E. Manson, Linda G. Snetselaar, Fred K. Tabung, Johanna W. Lampe, Marian L. Neuhouser · 2025 · Journal of Nutrition
  3. Nahrungsergänzungsmittel im Kontext sozialer Medien: Ergebnisse einer Befragung zur Nutzung und Wahrnehmung in Deutschland
    Henri Obstfeld, Mark Lohmann · 2025 · Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz
  4. Nahrungsergänzungsmittel und angereicherte Lebensmittel: Nutzen, Risiken und Maßnahmen für den Verbraucherschutz
    Carolin Bendadani, Nadiya Bakhiya, Evelyn Breitweg‐Lehmann, Anke Ehlers, Karen Ildico Hirsch‐Ernst, Birgit Liebscher, Anke Weißenborn · 2025 · Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz
  5. Assessing pharmacists’ knowledge and practices involving dietary supplement omega-3 fatty acids
    James M. Backes, Craig James Beavers, Dave L. Dixon, Cheryl Gibson, Daniel E. Hilleman, Mark A. Malesker, Joseph J. Saseen, Danielle B. Dilsaver · 2025 · Journal of clinical lipidology
  6. Serum Vitamin D Levels Over Time and the Incidence of Atrial Fibrillation in the HUNT Study
    Lin Jiang, Yi‐Qian Sun, Vegard Malmo, Xiao‐Mei Mai · 2025 · Journal of the Endocrine Society
  7. Advances in cardiovascular supplementation: mechanisms, efficacy, and clinical perspectives
    Xun Wu, Tanwei Fang · 2026 · Frontiers in Molecular Biosciences
  8. Fish oil supplements in patients with chronic kidney disease
    Charles Joseph Ferro, Mark Roland Thomas, Sophia Khattak, Dimitrios Chanouzas, John Townend · 2026 · Clinical Kidney Journal
  9. The CARDIOLIPID Plan: A Cardiovascular Risk-centred Implementation Framework for the Diagnosis and Management of Dyslipidaemia: Experts’ Proposal
    Stanisław Surma, Marcin Barylski, Roland Erich Schmieder, Claudio Borghi, Giuseppe Mancia, Gregory Y.H. Lip, Krzysztof Jerzy Filipiak · 2026 · European Cardiology Review
  10. Comparative Risk of the Onset of Atrial Fibrillation after Icosapent Ethyl versus Omega-3 –Acid-Ethyl-Esters Adjuvant to Statins
    Jyotirmoy Sarker, Michael Kim, Samantha Patton · 2024 · medRxiv
  11. Investigating the relationship between serum vitamin D levels over time and the incidence of atrial fibrillation in The HUNT Study
    Lin Jiang, Yi‐Qian Sun, Vegard Malmo · 2025 · medRxiv
  12. Response to: Correspondence on ‘Omega-3 supplementation and cardiovascular disease: formulation-based systematic review and meta-analysis with trial sequential analysis’ by Kountouras et al
    Georgios Markozannes, Evangelia Ntzani, Evangelos C. Rizos · 2022 · Heart
  13. Supplementierung mit Omega-3-Fettsäuren steigert Risiko für Vorhofflimmern
    2022 · DMW - Deutsche Medizinische Wochenschrift
  14. Fish oil and risk of atrial fibrillation: yet another paragon of the association or causation dilemma
    Fabrice Extramiana, Antoine Leenhardt · 2022 · European Journal of Preventive Cardiology
  15. Do Fish Oil Supplements Reduce A-Fib?
    Hekmat B. Khoukaz, Manisha Vadali, William P. Fay · 2022 · PubMed Central
  16. Omega-3 Fatty Acids and Atrial Fibrillation
    Peder Langeland Myhre · 2023 · Journal of the American College of Cardiology
  17. Omega-3 Fatty Acids and Atrial Fibrillation Risk
    Hao Chen, Yunan Xu · 2023 · Journal of the American College of Cardiology
  18. Oral Infections, SARS-CoV-2 Infection, and Autoimmunity
    Sok‐Ja Janket, Faleh Tamimi, Jukka H. Meurman · 2024 · Elsevier eBooks
  19. Safety update: omega-3-acid ethyl esters and atrial fibrillation
    BMJ Publishing Group Ltd · 2024 · Drug and Therapeutics Bulletin
  20. OMEGA-3 POLYUNSATURATED FATTY ACIDS ADMINISTRATION IN PREVENTION OF POSTOPERATIVE ATRIAL FIBRILLATION DURING CORONARY ARTERY BYPASS GRAFT SURGERY
    Olesya A. Rubanenko, А. О. Рубаненко · 2024 · Complex Issues of Cardiovascular Diseases
  21. Oméga-3 et psychiatrie : que dit la littérature ?
    Ariel Frajerman · 2024 · Annales Médico-psychologiques revue psychiatrique
  22. Oily Fish Intake and Cardiovascular Diseases: A Mendelian Randomization Study
    Xin Liu, Ankun Chen, Yating Lou, Chengcheng Zhang, Zenghui Yue · 2024 · Research Square
  23. 気分障害におけるサプリメント
    岳 寺尾 · 2024 · Kyushu Neuropsychiatry
  24. Enhancing tofacitinib’s therapeutic efficacy in murine arthritis with a synbiotic formulation comprising Bacillus megaterium DSM 32963 and an Omega-3 fatty acid lysine salt
    Annette Zehrer, Alexandra Rausch, Paul Mike Jordan, Oliver Werz, Heike tom Dieck, Thomas W. Berngruber · 2025 · Frontiers in Immunology
  25. Comparative Risk of Atrial Fibrillation Onset in Statin‐Treated Patients Initiating Icosapent Ethyl and Omega‐3 Acid Ethyl Esters: A Retrospective Cohort Study
    Jyotirmoy Sarker, Michael Kim, Samantha Patton · 2025 · Journal of the American Heart Association
  26. Genetic Epidemiological Evidence Indicates the Role of Lipid Control in Omega - 3 – Mediated Cardiovascular Protection
    Jinhan Yu, Chengjia LI, Zipeng Liu, Y.-D.I. Chen, Lei Yao, Dingyang Li, Wen Ma, Yao Wang, Yi Yang, Renzhi Wang et al. · 2025 · medRxiv
  27. Potential Confounders of the Different Impact of Alcohol Intake Between Sexes on the Incidence of Atrial Fibrillation
    Yu Nomoto, Naoya Kataoka, Teruhiko Imamura · 2025 · Journal of Arrhythmia
  28. Systems biology modelling based evaluation of omega-3 formulation in managing cardiovascular and cerebrovascular risk
    Sanjaay Balakrishnan, Abha Saxena, Madhusmita Mahapatra, Aparna Damle, Shyam Ramakrishnan, Palaniyamma Durairaj, Kareenhalli Viswanath Venkatesh · 2025 · Scientific Reports
  29. Lifestyle Modification: Diet, Exercise, Sports, and Other Issues
    Eli M Friedman, Matthew W. Martinez · 2025 · Springer eBooks
  30. Does parenteral Omega-3 fatty acid administration increase the risk of atrial fibrillation? An analysis of the current evidence
    Wolfgang H. Hartl, Patrick Meybohm, Matthias Pirlich, Konstantin Mayer, Gunnar Elke, Christian Stoppe, Christian von Loeffelholz · 2025 · Clinical Nutrition
  31. Additional file 1 of Effect of sacubitril/valsartan on lipid metabolism in patients with chronic kidney disease combined with chronic heart failure: a retrospective study
    Manzhi Li, Ao Zhong, Tang, Yifan, Jinnuo Yu, Wu, Mengmeng, Karthick Kumaran Munisamy Selvam, Sun, Dong · 2024 · Figshare
  32. Effects of fish oil supplementation on biomarkers of vascular endothelial function in middle-aged and older adults: a randomized controlled trial
    Chunxia Quan, Wei Tang, Yuting Qin, Zhaoyang Nian, Zhongxia Li, Limei Mao · 2026 · Food & Function
  33. Nutrition fonctionnelle en santé intégrative : une approche systémique face aux maladies chroniques
    Lizette Scialom · 2025 · HEGEL - HEpato-GastroEntérologie Libérale
  34. Circulating fatty acid profiles and risk of pulmonary arterial hypertension: Evidence from a large prospective cohort study
    Shuo Liu, Haobei Yuan, Jingxian Cao · 2026 · Medicine
  35. A Preventive Neurology Perspective on Promoting Brain Health and Preventing Cardiovascular Disease
    Sara Murray, Kiarra Akiyoshi, Richard Isaacson, Thomas D. Dayspring, Kellyann Niotis · 2026 · Clinics in Geriatric Medicine
  36. Novel risk model for predicting incident atrial fibrillation in patients taking ω−3 fatty acid: sub-analysis of the STRENGTH randomized trial
    Tom Kai Ming Wang, Stephen J Nicholls, Clement Tan, Becky Yi-Wen Liao, Kathy Wolski, Julie St. John, Steven E. Nissen · 2026 · American Journal of Preventive Cardiology
  37. Impact de l'acide eicosapentaénoïque (EPA), acide gras polyinsaturé n-3, sur l'efflux du cholestérol ABCA1-dépendant des macrophages humains
    Ludovic Dakroub · 2023 · theses.fr (ABES)
  38. Association between circulating ω-3 polyunsaturated fatty acid levels and left cardiac myocardial strain in hypertension: a CMR-FT study
    Linzhuo Cui, Aoran Xing, Ming Liu, Ting Wei, Jianbo Lyu, Xiaofeng Qu · 2026 · Frontiers in Nutrition
  39. Effect of Omega-3 Fatty Acid Intake on Circulating Biomarkers of Atrial Fibrillation-Related Pathways in the PREDIMED-Plus Study
    Jaime Lara Moreno, Linzi Li, Álvaro Alonso, Dora Romaguera, Ángel M. Alonso‐Gómez, Cristina Razquín, Lucas Tojal‐Sierra, Miquel Fiol, Miguel Ángel Martínez‐González, Vinita Subramanya et al. · 2026 · Nutrients
  40. Dosing effects of omega-3 fatty acid interventions in adults with migraine: Systematic review and meta-analysis of randomized clinical trials
    Christoper Alexander Alarcon-Ruiz, Paola Romero, Fátima Jiménez-Mozo, Frank Mayta-Tovalino, Andrés Pacherres-López, Fernando Miguel Runzer-Colmenares, Mario F P Peres · 2026 · Cephalalgia Reports
  41. Reframing Nutraceuticals in Knee Osteoarthritis with Sarcopenia: A Muscle–Joint-Centered Narrative Review
    Dojoon Park, Hae-Seok Koh, Youn‐Ho Choi, Jeong Wook Moon, Ilkyu Park · 2026 · Nutrients
  42. Proresolving mediators as cardiovascular biomarkers: solo players or an orchestra?
    Luís Miguel Santos, Magnus Bäck · 2026 · European Heart Journal Open
  43. Beyond Bone Health: Exploring the “Heart–Brain–Bone” Axis Modulated by Lipid-Soluble Nutrients (Omega-3, Vitamin D3, and Vitamin K2)
    Shih‐Chin Fang, Meng-Kai Huang, Hsieh-Tsung Ethan Shen, Bo-Xiang Benjamin Zhang, Ting-Hsuan Collette Chao, Chung-Che Wu · 2026 · Nutrients
  44. Österreichischer Lipidkonsensus 2026
    Florian Kronenberg, Florian Höllerl, Helmut Brath, Gersina Rega‐Kaun, Susanne Greber‐Platzer, Christoph Weiser, Dominic P Klein, Nikolaus Riesenhuber, Christoph J. Binder, Johanna Maria Brix et al. · 2026 · Wiener klinische Wochenschrift
  45. Omega-3-Fortified Foods as Designed Delivery Systems: Source Quality, Matrix Performance, Retained Dose, and Evidence-Based Claims
    Wojciech Kolanowski, Roberta Foligni · 2026 · Applied Sciences
  46. Omega-3 Polyunsaturated Fatty Acid Formulations in Cardiovascular Prevention: Balancing Clinical Efficacy, Safety, and Environmental Sustainability
    Filippo Egalini, Enrico Riccio, Marco Grasso, Anna Nelva, Vincenzo De Geronimo · 2026 · Nutrients
  47. Moderne F.X.-Mayr-Medizin mit Fokus auf die Frau
    Stephanie Barth · 2026 · Zeitschrift für Komplementärmedizin
  48. Circulating lipid profiles and atrial fibrillation: from incident risk to post-ablation recurrence
    Mi Yan, Jingfeng Zou, Wen Peng · 2026 · Frontiers in Cardiovascular Medicine
  49. Food and Health: Nutrition for Prevention and Management of Cardiovascular Disease: 2026 ACC Scientific Statement
    Frank B. Hu, Branko Beleslin, Michael Joseph Blaha, Penny M. Kris-Etherton, Hilary Kessler Seligman, Kim Allan Williams · 2026 · Journal of the American College of Cardiology
  50. Omega-3 Fatty Acids in the Management of Cardiovascular Disease Prevention
    Simone Finocchiaro, Luigi Cutore, Costanza Bordonaro, Carmelo Cusmano, Diego Nastasi, Francesco Nasisi, Davide Capodanno · 2026 · Cardiovascular Drugs and Therapy